What is biote Corp. worth?
With the base-case assumptions below, a discounted cash flow model on biote Corp.'s reported free cash flow gives $15.38 per share. The share price was $1.22 on September 25, 2026, 92% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 3.5% | 10.0% | $8.41 | +589% |
| Base | 8.5% | 9.0% | $15.38 | +1,161% |
| Bull | 13.5% | 8.0% | $29.28 | +2,300% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $20.59 | $22.19 | $24.15 | $26.59 | $29.73 |
| 8.0% | $16.70 | $17.73 | $18.96 | $20.43 | $22.23 |
| 9.0% | $13.85 | $14.56 | $15.38 | $16.33 | $17.46 |
| 10.0% | $11.69 | $12.19 | $12.76 | $13.42 | $14.17 |
| 11.0% | $9.99 | $10.36 | $10.77 | $11.24 | $11.76 |
Where the presets come from
Base: years 1 to 5 grow at biote Corp.'s revenue growth rate over the last 4 fiscal years (8.4% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions